You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金活醫藥集團(01110.HK)2020年純利跌73.0%至1171.6萬元 末期息0.65港仙
格隆匯 03-31 22:03

格隆匯3月31日丨金活醫藥集團(01110.HK)公佈2020年度業績,期內集團實現收益7.45億元人民幣(單位下同),同比下降23.8%;毛利2.80億元,同比增長4.8%,毛利率由上年同期的27.3%升至37.6%;公司擁有人應占溢利1171.6萬元,同比下降73.0%;每股基本盈利1.91分,宣派末期股息每股0.65港仙。

公吿稱,收益減少主要原因為京都念慈庵蜜煉川貝枇杷膏及康萃樂益生菌產品系列的收益減少所致。該兩項下跌主要原因為受到疫情的負面影響所致,由於疫情令人流和物流受到影響,市場對本集團的藥品及保健品的需求都有所下降。惟部份給東迪欣生產的醫療設備產品,包括紅外線測温儀,銷售增加所抵銷。此類防疫產品於回顧年度內需求很大。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account